Kenya BioVax Institute, a vaccine manufacturer, is at an advanced stage of setting up a facility at Konza Technopolis, signaling the country’s progress towards locally manufacturing human vaccines.
Dr Lusiola said the country is well on track to realise the dream of locally manufacturing human vaccines, starting downstream fill-and-finish.
“We are speeding up efforts to see Kenya package vaccines locally within the next four years, which will be the first step to locally manufacturing them,” Lusiola said in a statement.
Health Cabinet Secretary Susan Nakhumicha has emphasized Kenya’s goal of becoming a regional hub for specialized health products and technologies, particularly vaccines for childhood, adolescent girls, and maternal immunization.
The country is actively engaging in collaborations for vaccine manufacturing, aiming to meet the growing demand in the region.